entertainment -WSS

entertainment

author：leisure time 2025-09-14 18:32:32 - browse：22351

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Nonprofit, backed by Microsoft, to certify AI tools in health care

WSS

Clinical trials giant ICON acquires HumanFirst

Study suggests new cause of Down syndrome: cells linked to aging

Male doctors called my cancer incurable. A female doctor showed it wasn't

A Q&A with Aletha Maybank, AMA’s chief health equity officer

House looks to weaken Medicare negotiation

Congress gives doctors Medicare pay bump

Wikipedia

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

ChatGPT in medicine: STAT answers readers' burning questions

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Boston Scientific acquires urology company Axonics for $3.7 billion

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Obesity now affects over 1 billion people worldwide, study finds

In Memoriam: Notable people who died in 2023

Obesity now affects over 1 billion people worldwide, study finds

Bright Health sells Medicare Advantage business to Molina

Does Paxlovid work in people vaccinated against Covid

Wikipedia

Covid isolation guidance eased by the CDC

Does Paxlovid work in people vaccinated against Covid

Profiling embryos to choose those with higher IQs is almost a reality

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Covid isolation guidance eased by the CDC

Boston Scientific acquires urology company Axonics for $3.7 billion

explore

hotspot

hotspot

Wikipedia